• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Enlivex Therapeutics Ltd. - Ordinary Shares (NQ:ENLV)

    1.170 +0.090 (+8.33%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 675,875
    Open 1.090
    Bid (Size) 1.140 (100)
    Ask (Size) 1.180 (600)
    Prev. Close 1.080
    Today's Range 1.050 - 1.200
    52wk Range 0.6600 - 2.100
    Shares Outstanding 18,306,186
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Enlivex Treasury Portfolio Update: Listing of the RAIN Token on WhiteBIT, a Leading Cryptocurrency Exchange
    From Enlivex Therapeutics Ltd
    Via GlobeNewswire
    News headline image
    Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq
    From Enlivex Therapeutics Ltd
    Via GlobeNewswire

    Performance

    YTD
    +55.0%
    +55.0%
    1 Month
    +56.5%
    +56.5%
    3 Month
    +8.3%
    +8.3%
    6 Month
    -7.1%
    -7.1%
    1 Year
    +1.7%
    +1.7%

    More News

    Read More
    News headline image
    Enlivex Treasury Portfolio Update: Listing of the RAIN Token on KuCoin, a Leading Cryptocurrency Exchange
    From Enlivex Therapeutics Ltd
    Via GlobeNewswire
    News headline image
    Enlivex Management to Host Fireside Chat on December 11 to Discuss RAIN Token Strategy and Allocetra Clinical Development
    From Enlivex Therapeutics Ltd
    Via GlobeNewswire
    News headline image
    Enlivex Announces Closing of Previously Announced $212,000,000 Private Placement
    From Enlivex Therapeutics Ltd
    Via GlobeNewswire
    News headline image
    Kartoon Studios Mainframe Studios, Toon Media, and Premium IP Pipeline Drive 2026-2027 Outlook
    Via AB Newswire
    News headline image
    Which stocks are experiencing notable movement on Monday? ↗
    Via Chartmill
    News headline image
    These stocks are making the most noise in today's session. ↗
    Via Chartmill
    News headline image
    Top movers in Monday's session ↗
    Via Chartmill
    News headline image
    The market is filled with gapping stocks in Monday's session. ↗
    Via Chartmill
    News headline image
    ENLV Stock Surges After Pivot To Crypto-Backed Treasury, Names Former Italian PM To Board ↗
    Via Stocktwits
    Topics ETFs
    News headline image
    Wondering what's happening in today's pre-market session? ↗
    Via Chartmill
    News headline image
    Enlivex Announces $212,000,000 Private Placement to Initiate World’s First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board
    From Enlivex Therapeutics Ltd
    Via GlobeNewswire
    News headline image
    Enlivex Announces Positive 6-Month Topline Data –Demonstrating Durable and Persistent Pain Reduction and Improved Function in Primary Age-Related Patients with Moderate to Severe Knee Osteoarthritis
    From Enlivex Therapeutics Ltd
    Via GlobeNewswire
    News headline image
    Enlivex Therapeutics to Present Phase IIa 3-month Data of Allocetra in Patients with Moderate-to-Severe Knee Osteoarthritis at the ACR Convergence 2025
    From Enlivex Therapeutics Ltd
    Via GlobeNewswire
    News headline image
    Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESS Newswire
    News headline image
    D. Boral Capital to Host KOL Webinar With World Leading Experts Featuring Insights & Breakthroughs from Enlivex's Knee Osteoarthritis Program
    From Enlivex Therapeutics Ltd
    Via GlobeNewswire
    News headline image
    Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESS Newswire
    News headline image
    Enlivex CEO Issues Letter to Shareholders Outlining Strategic Roadmap Following Positive Phase IIa Allocetra™ Results
    From Enlivex Therapeutics Ltd
    Via GlobeNewswire
    News headline image
    Enlivex Announces Issuance of New Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis
    From Enlivex Therapeutics Ltd
    Via GlobeNewswire
    News headline image
    What's going on in today's session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
    Via Benzinga
    News headline image
    Monday's session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    Enlivex Announces Positive Topline Data From Multi-Country, Randomized, Controlled, Phase I/II Trial Evaluating Allocetra in Patients With Moderate-To-Severe Knee Osteoarthritis
    From Enlivex Therapeutics Ltd
    Via GlobeNewswire

    Frequently Asked Questions

    Is Enlivex Therapeutics Ltd. - Ordinary Shares publicly traded?
    Yes, Enlivex Therapeutics Ltd. - Ordinary Shares is publicly traded.
    What exchange does Enlivex Therapeutics Ltd. - Ordinary Shares trade on?
    Enlivex Therapeutics Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Enlivex Therapeutics Ltd. - Ordinary Shares?
    The ticker symbol for Enlivex Therapeutics Ltd. - Ordinary Shares is ENLV on the Nasdaq Stock Market
    What is the current price of Enlivex Therapeutics Ltd. - Ordinary Shares?
    The current price of Enlivex Therapeutics Ltd. - Ordinary Shares is 1.170
    When was Enlivex Therapeutics Ltd. - Ordinary Shares last traded?
    The last trade of Enlivex Therapeutics Ltd. - Ordinary Shares was at 01/26/26 04:00 PM ET
    What is the market capitalization of Enlivex Therapeutics Ltd. - Ordinary Shares?
    The market capitalization of Enlivex Therapeutics Ltd. - Ordinary Shares is 21.42M
    How many shares of Enlivex Therapeutics Ltd. - Ordinary Shares are outstanding?
    Enlivex Therapeutics Ltd. - Ordinary Shares has 21M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.